From ADC to XDC: Opportunities and challenges for AI in revolutionizing drug conjugate development

Authors

Xiaogang Wang (ORCID: https://orcid.org/0000-0003-3297-8081)
Meiyang Liu (ORCID: https://orcid.org/0009-0004-5158-3856)

Publication Details

Journal: The Innovation Medicine
Published: 2024-12-18
DOI: https://doi.org/10.59717/j.xinn-med.2024.100107
Citations: 1
Primary Topic: Computational Drug Discovery Methods
Type: article
Field-Weighted Citation Impact: 0.36

Funders

National Natural Science Foundation of China

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

From ADC to XDC: Opportunities and challenges for AI in revolutionizing drug conjugate development

Xiaogang Wang, Meiyang Liu

Dec 18, 2024

1 citations

The Innovation Medicine

Computational Drug Discovery Methods

0.36

article

From ADC to XDC: Opportunities and challenges for AI in revolutionizing drug conjugate development

Xiaogang Wang, Meiyang Liu

December 18, 2024article en

1 citations

Abstract

No abstract available for this paper.

The Innovation MedicineVol. 3(1)

National Natural Science Foundation of China

Gender equality

Openalex Percentile: Top 33%

Computational Drug Discovery Methods

0.36

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

From ADC to XDC: Opportunities and challenges for AI in revolutionizing drug conjugate development — Xiaogang Wang, Meiyang Liu · The Innovation Medicine (2024) | TGRS Research Map | TGRS